Asia Pac ECM and Index Rebal, DZT Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac ECM and Index Rebal

MS-China June 2026 Rebalance: Pre-Implementation Update

MS-China March 2026 Rebalance: Post-Event Review

MS-China Index Earning Revision (Mar): PDD, UNITED NOVA TECHNOLOGY, MEITUAN, TENCENT, ALIBABA

MS-China Index Earning Revision (Feb): ALIBABA, TENCENT, PDD

Asia Pac IPO & Placement Research, China Biotech

DZT Research

DZT Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Index Rebalance

<ul>
<li>We analyzed the post-announcement return pattern of MSCI China June 2026 rebalance stocks, separating A-share (CH) and H-share (HK) cohorts within both ADD and DELETE groups.</li>
<li>DELETE: pre announcement was positive, but CH and HK High-vel history still supports shorts.</li>
<li>ADD: CH High-vel was stretched; bridging window's history is positive but inconsistent.</li>
</ul>


We analyzed the post-announcement return pattern of MSCI China June 2026 rebalance stocks, separating A-share (CH) and H-share (HK) cohorts within both ADD and DELETE groups.
DELETE: pre announcement was positive, but CH and HK High-vel history still supports shorts.
ADD: CH High-vel was stretched; bridging window's history is positive but inconsistent.


COSCO SHIPPING Energy Transportation (1138 HK)

China CITIC Financial Asset Management (2799 HK)

Shandong Weigao Group Medical Polymer (1066 HK)

Jiangsu Yuyue Medical Equipment & Supply A (002223 CH)

Jiangsu Yuyue Medical Equipment & Supply A

Jiangsu King's Luck Brewery JS (603369 CH)

China Railway Signal & Communi (688009 CH)

Guangzhou Baiyunshan Pharmaceu (600332 CH)

Everdisplay Optronics Shanghai (688538 CH)

Sichuan Biokin Pharmaceutical (688506 CH)

Shenzhen Zhaowei Machinery & Electronics (2692 HK)

MS-중국 2026년 6월 리밸런싱: 발표 후 거래 패턴 분석

Kingboard Laminates

MS-중국 2026년 6월 리밸런싱: 발표 후 거래 패턴 분석